cardiology MCQ (SBA): AHA/ACC/HFSA Guideline (2022): Management of Heart Failure

Instant feedback + full explanation. One question, done properly.

MediumHR ≥70 bpm on maximally tolerated beta-blocker to reduce HF hospitalization. Non-DHP CCBs (verapamil/diltiazem) are harmful in HFrEF. Digoxin does not primarily target HR and is not first to reduce hospitalizations. Amiodarone is for arrhythmia controlAHA/ACC/HFSA Guideline (2022): Management of Heart Failurecardiology

A 61-year-old man with HFrEF (EF 25%) and sinus rhythm has resting HR 82 bpm on max tolerated beta-blocker. Which additional rate-targeting drug may reduce HF hospitalization if criteria met?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

cardiology MCQ: AHA/ACC/HFSA Guideline (2022): Management of Heart Fai